Found 10 matching trials
Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma
PHASE1This is a Phase 1 clinical trial to evaluate a new combination of drugs for...
Location
University of Chicago Medical Center
Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence
PHASE3The objective of this study is to determine whether pomalidomide is safe an...
Pomalidomide for Myelofibrosis Patients
PHASE2The goal of this clinical research study is to learn if CC-4047 (now called...
Location
University of Texas MD Anderson Cancer Center
A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors
PHASE2This study will assess the efficacy, safety and tolerability of pomalidomid...
Location
Stanford University Cancer Center
Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF
PHASE1The proposed study is an open-label, single-arm, Phase-Ib/II trial to asses...
Location
UniversitÀtsklinikum Aachen - Med. Klinik IV
A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
PHASE2The purpose of this study is to determine the safety of and to select a tre...
Location
UCLA School of Medicine Hematology/Oncology
Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
PHASE2This is a phase II, multi-center study of pomalidomide in adult patients wi...
Location
UniversitÀtsklinikum Aachen
Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease
PHASE1The purpose of the study is to determine the maximum tolerated dose, safety...
Location
Karmanos Cancer Institute
A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects
PHASE1To evaluate the safety, tolerability, and pharmacokinetics of pomalidomide ...
Location
PPD Phase I Clinic
Pomalidomide for Chronic Graft-versus-Host Disease
PHASE2Background:
\- Pomalidomide is a drug that alters the body's immune respon...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike